The short-term effect on alliance and satisfaction of using patient feedback scales in mental health out-patient treatment. A randomised controlled trial

Table 4 Per protocol analyses

Outcomes	Group	Baseline	Between groups at 6 weeks A)			Within groups (6 weeks–baseline) B)
		Mean (SD)	Mean (SD)	Diff. (95% CI)		Diff (95% CI)	p-value
TAS	INT		5.01 (0.8)	0.32 (−0.11, 0.75)	0.137
TAS	CTRL		4.69 (0.8)
CSQ	INT		25.59 (4.0)	1.16 (−0.84, 3.16)	0.248
CSQ	CTRL		24.43 (3.6)
BASIS-32 ^†	INT	1.10 (0.5)	1.03 (0.5)	0.04 (−0.22, 0.30)		−0.07 (−0.27, 0.14)	0.515
BASIS-32 ^†	CTRL	1.27 (0.6)	1.09 (0.6)		0.766	−0.18 (−0.37, 0.01)	0.069
PAM	INT	35.17 (6.4)	39.43 (7.0)	2.53 (−2.04, 7.10)	0.272	4.26 (1.71, 6.81)*	0.002
PAM	CTRL	36.17 (8.8)	37.29 (10.5)			1.12 (−3.15, 5.40)	0.596
MCS (SF-12)	INT	37.41 (7.5)	39.94 (7.8)	−0.29 (−4.21, 3.63)	0.883	2.54 (−0.40, 5.48)	0.088
MCS (SF-12)	CTRL	37.37 (6.1)	40.21 (8.5)			2.84 (−0.23, 5.92)	0.069
PCS (SF-12)	INT	47.46 (8.4)	48.84 (9.9)	1.42 (−2.20, 5.04)	0.434	1.38 (−1.48, 4.24)	0.330
PCS (SF-12)	CTRL	48.09 (8.6)	47.90 (9.0)			−0.18 (−2.70, 2.34)	0.883
ORS	INT	17.55 (7.0)	22.07 (9.0)	2.68 (−1.74, 7.09)	0.229	4.52 (1.31, 7.73)*	0.008
ORS	CTRL	16.16 (7.0)	18.63 (9.2)			2.47 (−0.94, 5.89)	0.150
SRS	INT		34.68 (5.6)	3.15 (0.07, 6.37)	0.055
SRS	CTRL		31.53 (6.4)
PM	INT	5.38 (0.8)	5.65 (0.5)	0.28 (0.04, 0.42)	0.024	0.27 (−0.04, 0.57)	0.081
PM	CTRL	5.32 (0.9)	5.34 (0.7)			0.02 (−0.14, 0.19)	0.788
PP	INT		4.73 (0.7)	0.07 (−0.29, 0.42)	0.706
	CTRL		4.66 (0.6)

Comparison of outcomes between the intervention group (INT, n = 26) and control group (CTRL, n = 32) six weeks after treatment start, and within each group from baseline to six weeks.
TAS = Treatment alliance score, CSQ = Client satisfaction questionnaire, BASIS-32 = The behavior and symptom identification scale 32, PAM = Patient activation measure, MCS (SF-12) = Mental Component Score (Short form-12), PCS (SF-12) = Physical Component Score (Short form-12), ORS = Outcome rating scale, SRS = Session rating scale, PM = Patient motivation, PP = Patient participation.
A) The between-group mean differences for TAS, CSQ, SRS and PP have been calculated using two-tailed independent t-tests. The between-group estimated mean differences for BASIS-32, PAM, SF12, ORS, and PM have been calculated using analysis of covariance (ANCOVA), adjusted for baseline values.
B) The within group differences have been calculated using two-tailed paired t-test.
^† Decrease in score indicates improvement (less mental health symptoms) for BASIS-32. For the other outcomes, increased score indicates improvement.
* p-value ≤0.05.

ISSN: 1472-6963